The Role of IL33/ST2 Axis in ARDS Patients

Completed

• Conditions: Acute Respiratory Distress Syndrome

• Registration Number: NCT02492204
• Lead Sponsor: Hospital Universitari Vall d'Hebron Research Institute

Brief Summary

The main objective is the study of the role of IL33/ST2 axis in the pathogenesis of ARDS, it´s value as prognosis marker and as therapeutic target.

Detailed Description

Not available

Study Timeline

• Study Start: 2015-07
• Primary Completion: 2015-07
• Study First Submitted: 2015-07-03
• Study First Submitted QC: 2015-07-03
• Study First Posted: 2015-07-08
• Status Verified: 2018-01
• Last Update Submitted: 2019-02-24
• Last Update Posted: 2019-02-26
• Study Completion: 2019-12

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 200

Inclusion Criteria

• ARDS
• Risk pathologies to develop ARDS (sepsis, pancreatitis, pneumonia, massive transfussion, politraumatics)

Exclusion Criteria

• Age under 18
• Pregnancy
• Undergoing a clinical trial

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Prognostic value of the IL-33/ST2 axis in patients with ARDS.	60 days

Secondary Outcome Measures

Name	Time	Method
Value of IL33/ST2 axis to predict development of ARDS in risk patients	60 days

Trial Locations

Locations (1)

Hospital Universitary Vall d´Hebron; 🇪🇸 Barcelona, Spain